Smartaging.com will help you age smarter, better and more comfortably by connecting you with the home health and home medical equipment, nutritional products and health monitoring tools you or a loved one need.
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
Nearly all Americans over 65 got their initial Covid vaccines. But that immunity is waning, and this time, the government is offering far less support for new shots.
A new federal program offers hefty payments to small hospitals at risk of closing. But it comes with a bewildering requirement: to end all inpatient care.
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
The federal government recently lifted most visitation restrictions at nursing homes. But concerns linger that a full reopening could leave residents vulnerable to another coronavirus surge.
